• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Matinas Biopharma Hl (NY: MTNB )

    0.5819 -0.0381 (-6.15%)
    Official Closing Price Updated: 8:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Matinas Biopharma Hl

    < Previous 1 2 3 4 Next >
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results
    Via Benzinga
    Exposures Fossil Fuels
    Nasdaq Down Over 200 Points; Microsoft Shares Fall After Q1 Results
    Via Benzinga
    Looking Into Matinas BioPharma Hldgs's Recent Short Interest
    Via Benzinga
    Matinas BioPharma Hldgs's Earnings: A Preview
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    MTNB Stock Earnings: Matinas BioPharma Hldgs Meets EPS for Q2 2024
    MTNB stock results show that Matinas BioPharma Hldgs met analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch
    Penny stocks to buy understandably offers many enticing attributes, not least of which is the potential for tremendous returns. 
    Via InvestorPlace
    MTNB Stock Earnings: Matinas BioPharma Hldgs Meets EPS for Q1 2024
    MTNB stock results show that Matinas BioPharma Hldgs met analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    MTNB Stock Earnings: Matinas BioPharma Hldgs Reported Results for Q4 2023
    Matinas BioPharma Hldgs just reported results for the fourth quarter of 2023. 
    Via InvestorPlace
    Why Is Fungal Infections-Focused Matinas BioPharma Stock Trading Higher On Friday?
    Progress with Matinas BioPharma's MAT2203 for invasive fusarium infection. Clinical response achieved in patients resistant to other antifungals. 
    Via Benzinga
    Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per... 
    Via Benzinga
    Why Is Inflammatory Focused Matinas BioPharma Stock Trading Higher Today?
    Wednesday, Matinas BioPharma Holdings Inc (NASDAQ: MTNB) announced results from a series of in vivo studies demonstrating successful oral delivery of two lipid nanocrystal (LNC)-formulated small... 
    Via Benzinga
    What's Going On With Matinas Biopharma Holdings Stock?
    Matinas Biopharma Holdings, Inc. (AMEX:MTNB) shares are trading higher on Wednesday after the company announced complete clinical resolution of a patient's recurrent hemorrhagic cystitis following... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Semler Scientific Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
    Gainers Amyris, Inc. (NASDAQ: AMRS) shares surged 45.4% to $0.0958 in pre-market trading. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
    Gainers PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) shares surged 46.7% to $0.64 in pre-market trading after gaining 6% on Wednesday. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning! 
    Via InvestorPlace
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.